AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash
(feeds.content.dowjones.io)
1.
2.
Incyte to Buy Vega Therapeutics For Up to $2 Billion
(feeds.content.dowjones.io)
3.
Gilead Sciences to Buy Clinical-Stage Biotech Tubulis for Up to $5 Billion
(feeds.content.dowjones.io)
4.
Novocure Gets FDA Approval for Pancreatic Cancer Treatment; Shares Soar
(feeds.content.dowjones.io)
5.
Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products
(feeds.content.dowjones.io)